DrugSep 18, 2024
Elevate Oral Care Just Right 5000, 1.1% Sodium Fluoride, Candy Apple Flavor, Net Wt. 3.4oz recall — FDA D-0658-2024
LABELING: LABEL MIX-UP.
Class IIIFDA: TerminatedElevate Oral Care
Recall records from September 2024
These records include useful source details for the selected month.
VehicleSep 13, 2024
F-150 lighting control module recall — NHTSA campaign 24V682000
Ford Motor Company (Ford) is recalling certain 2022 F-150 vehicles. The parking lights may flicker when the headlights are activated. As such, these vehicles fail to comply with the…
lighting control moduleFord Motor Company
VehicleSep 13, 2024
Tucson labels recall — NHTSA campaign 24V691000
Hyundai Motor America (Hyundai) is recalling certain 2025 Tucson vehicles. The glove box air bag warning label may be missing. As such, these vehicles fail to comply with the requirements…
labelsHyundai Motor America
VehicleSep 12, 2024
Jeep Wrangler camera recall — NHTSA campaign 24V676000
Chrysler (FCA US, LLC) is recalling certain 2018-2024 Jeep Wrangler vehicles. The wiring harness for the rearview camera and the center brake light may short circuit, which can disable the…
cameraChrysler (FCA US, LLC)
DrugSep 11, 2024
HEPARIN SODIUM IN SODIUM CHLORIDE Heparin recall — FDA D-0649-2024
Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing.
Class IFDA: OngoingBaxter Healthcare Corporation
VehicleSep 5, 2024
Chrysler control unit/module recall — NHTSA campaign 24V653000
Chrysler (FCA US, LLC) is recalling certain 2019, 2021-2024 Ram 1500 vehicles. Due to a software malfunction, the anti-lock brake system (ABS) control module may disable the electronic…
control unit/moduleChrysler (FCA US, LLC)
VehicleSep 5, 2024
Chrysler instrument cluster/panel recall — NHTSA campaign 24V652000
Chrysler (FCA US, LLC) is recalling certain 2020-2024 Jeep Gladiator and 2018-2024 Jeep Wrangler vehicles. The instrument panel cluster may experience an internal short circuit and fail. As…
instrument cluster/panelChrysler (FCA US, LLC)
DrugSep 4, 2024
IBU Ibuprofen Tablets, USP, 600 mg recall — FDA D-0645-2024
Failed impurities/degradation specifications: results for unknown impurity, were 0.13% and 0.11% respectively, exceeding the 0.10% specification limit.
Class IIFDA: OngoingDr. Reddy's Laboratories, Inc.
DrugSep 4, 2024
IBU Ibuprofen Tablets, USP, 400 mg recall — FDA D-0646-2024
Failed impurities/degradation specifications: results for unknown impurity, were 0.13% and 0.11% respectively, exceeding the 0.10% specification limit.
Class IIFDA: OngoingDr. Reddy's Laboratories, Inc.
DrugSep 4, 2024
Cefixime for Oral Suspension USP, 100 mg/5 mL, 50 mL bottle recall — FDA D-0648-2024
Subpotent Drug- An out of specification ( OOS ) result observed in assay test during 18-month long term stability study.
Class IIFDA: TerminatedLupin Pharmaceuticals Inc.
DrugSep 4, 2024
Indomethacin Extended-Release Capsules, USP, 75 mg recall — FDA D-0643-2024
Failed Dissolution Specifications: below specification results
Class IIFDA: OngoingGlenmark Pharmaceuticals Inc., USA
DrugSep 4, 2024
IBU Ibuprofen Tablets, USP, 800 mg recall — FDA D-0644-2024
Failed impurities/degradation specifications: results for unknown impurity, were 0.13% and 0.11% respectively, exceeding the 0.10% specification limit.
Class IIFDA: OngoingDr. Reddy's Laboratories, Inc.
How to use this monthly recall archive
Use this page to compare the recalls reported during the month, then open an individual record for the exact reason, classification, company, remedy or distribution information available from the official source. Monthly counts are descriptive, not a safety rating.